Pages that link to "Q54170215"

The following pages link to Activated protein C resistance: molecular mechanisms based on studies using purified Gln506-factor V. (Q54170215):

Displaying 14 items.

• American College of Medical Genetics consensus statement on factor V Leiden mutation testing (Q28361651) (← links)
• Prothrombotic phenotype of protein Z deficiency (Q28509678) (← links)
• High-density lipoprotein enhancement of anticoagulant activities of plasma protein S and activated protein C. (Q33835022) (← links)
• Prevalence of factor V Leiden in a Canadian blood donor population (Q34712722) (← links)
• Coagulation factor V mediates inhibition of tissue factor signaling by activated protein C in mice (Q36301525) (← links)
• Autolysis loop restricts the specificity of activated protein C: analysis by FRET and functional assays (Q36663039) (← links)
• Functional properties and active-site topographies of factor X Gla- and prothrombin Gla-domain chimeras of activated protein C (Q36953908) (← links)
• Late onset thrombosis in a case of severe protein S deficiency due to compound heterozygosity for PROS1 mutations. (Q37076730) (← links)
• Anticoagulant synergism of heparin and activated protein C in vitro. Role of a novel anticoagulant mechanism of heparin, enhancement of inactivation of factor V by activated protein C (Q37368145) (← links)
• Interdomain engineered disulfide bond permitting elucidation of mechanisms of inactivation of coagulation factor Va by activated protein C (Q38269759) (← links)
• Postmortem diagnosis of Factor V Leiden from paraffin wax embedded tissue. (Q40849379) (← links)
• Nonenzymatic anticoagulant activity of the mutant serine protease Ser360Ala-activated protein C mediated by factor Va (Q41142483) (← links)
• The effect of Arg306 → Ala and Arg506 → Gln substitutions in the inactivation of recombinant human factor Va by activated protein C and protein S (Q42201669) (← links)
• Prevalence of factor V Leiden in children with thrombo-embolism (Q71864621) (← links)